CEACAM5 and rectal cancer: Compared with TD-negative rectal cancer patients, TD-positive patients typically present with adverse features, such as elevated CEA levels, advanced TNM staging, and PNI (all P < 0.05), as previously reported (2, 10, 22, 23).